AstraZeneca Staking Its Growth On Oncology; Now It Needs Cancer Drugs

AstraZeneca has an ambitious agenda to become a leader in oncology. The company’s notably improved pipeline is broad, but winning will require AstraZeneca to come from behind to uncover the best combinations ahead of the competition.